TABLE 2:
Comparison of Cancer Characteristics Between Non-ICPI-Induced MC and ICPI-Induced MC in Cancer Patients
| Characteristic | No. Patients (%) | P | |
|---|---|---|---|
| Non-ICPI-Induced MC With Cancer | ICPI-Induced MC With Cancer | ||
| n = 39 | n = 15 | ||
| Cancer | 0.171 | ||
| Solid | 32 (82) | 15 (100) | |
| Hematologic | 7 (18) | 0 (0) | |
| Cancer stage for solid tumorsa | <0.001 | ||
| ≤II | 18 (67) | 0 (0) | |
| III/IV | 9 (33) | 15 (100) | |
| Cancer treatments | 0.714 | ||
| Single regimen | 7 (19) | 0 (0) | |
| Multiple regimens | 30 (81) | 15 (100) | |
aCancer stage is available only for 27 of 32 non-ICPI-induced MC cancer patients.